Valuation: The ACME Laboratories Ltd.

Market Cap 17.44B 141M 124M 115M 106M 199M 13.63B 202M 1.37B 536M 6.67B 530M 519M 23.04B P/E 2024
5.9x
P/E 2025 6.29x
Enterprise Value 40.31B 327M 286M 266M 244M 460M 31.52B 467M 3.17B 1.24B 15.42B 1.23B 1.2B 53.28B EV / Sales 2024
1.15x
EV / Sales 2025 1.06x
Free-Float
55.88%
Yield 2024
5.11%
Yield 2025 4.85%
1 day-0.95%
1 week-3.36%
Current month+1.33%
1 month+3.99%
3 months+8.87%
6 months+13.45%
Current year+17.77%
1 week 83.1
Extreme 83.1
86.4
1 month 80.2
Extreme 80.2
88.7
Current year 70.6
Extreme 70.6
88.7
1 year 68.6
Extreme 68.6
88.7
3 years 62.6
Extreme 62.6
94.5
5 years 62.6
Extreme 62.6
117.7
10 years 54.2
Extreme 54.2
122.4
Manager TitleAgeSince
Chief Executive Officer 82 1995-09-29
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 82 1975-03-16
Director/Board Member 76 1981-04-14
Chairman 69 2018-09-04
Change 5-day change 1-year change 3-year change Capi.($)
-0.95%-3.36%+5.96%-2.00% 143M
-1.05%+0.55%+49.79%+151.71% 1,037B
+2.00%+3.49%+52.22%+50.20% 615B
-1.09%+3.76%+35.37%+76.22% 448B
+2.17%+2.93%+30.62%+24.79% 326B
-1.01%+0.83%+33.46%+36.87% 293B
-1.54%-0.60%+17.59%+16.44% 264B
-1.68%-6.18%-28.85%-42.72% 216B
-0.05%+2.16%+19.75%+55.89% 198B
+0.05%-1.03%+18.31%+61.63% 162B
Average -0.40%+0.80%+23.42%+42.90% 355.76B
Weighted average by Cap. -0.46%+1.47%+35.04%+72.34%

Financials

2024 2025
Net sales 31.93B 259M 227M 210M 193M 364M 24.97B 370M 2.51B 981M 12.22B 971M 950M 42.2B 35.94B 291M 255M 237M 218M 410M 28.1B 416M 2.82B 1.1B 13.75B 1.09B 1.07B 47.5B
Net income 2.46B 19.9M 17.44M 16.19M 14.88M 28.03M 1.92B 28.44M 193M 75.48M 940M 74.71M 73.1M 3.25B 2.43B 19.68M 17.24M 16.01M 14.71M 27.72M 1.9B 28.13M 191M 74.64M 929M 73.87M 72.28M 3.21B
Net Debt 22.18B 180M 157M 146M 134M 253M 17.34B 257M 1.74B 682M 8.49B 675M 660M 29.31B 22.87B 185M 162M 151M 139M 261M 17.88B 265M 1.8B 703M 8.75B 696M 681M 30.23B
Logo The ACME Laboratories Ltd.
The ACME Laboratories Limited is a Bangladesh-based company, which is engaged in manufacturing, marketing, and distribution of pharmaceuticals formulation products. The Company is engaged in manufacturing, marketing, and distribution of generic pharmaceuticals formulation products, which include human drugs comprising dosages like a tablet, capsule, dry syrup, cream, ointment, powder, injection, dry powder inhaler, metered dosage inhaler, suppository, eye and nasal drop, liquid, liquid in hard gelatine, Blow Fill Seal (BFS) products, and sachet products. It also offers veterinary drugs comprising dosages like bolus, liquid, injection, water-soluble powder, premix, and herbal drugs comprising dosages like liquid, capsule, tablet, cream, and ointment. The products of the Company are sold in domestic and international markets, respectively. Its factory is situated at Dhulivita, Dhamrai, Dhaka, and Bangladesh. It produces approximately 800 products in different dosage forms.
Employees
9,025
Date Price Change Volume
26-07-22 BDT 83.50 -0.95% 669,961
26-07-21 BDT 84.30 0.00% 596,624
26-07-20 BDT 84.30 +0.36% 357,746
26-07-19 BDT 84.00 -1.52% 749,927
26-07-16 BDT 85.30 -1.27% 920,682
  1. Stock Market
  2. Stocks
  3. ACMELAB Stock